A new design of mandibular advancement device (IMYS) in the treatment of obstructive sleep apnea

Domenico Ciavarella; Alessandra Campobasso; Carmela Suriano; Eleonora Lo Muzio; Laura Guida; Fabio Salcuni; Michele Laurenziello; Gaetano Illuzzi; Michele Tepedino

doi:10.1080/08869634.2022.2041271

A new design of mandibular advancement device (IMYS) in the treatment of obstructive sleep apnea

Cranio. 2022 Feb 16:1-8. doi: 10.1080/08869634.2022.2041271. Online ahead of print.

Authors

Domenico Ciavarella¹, Alessandra Campobasso¹, Carmela Suriano¹, Eleonora Lo Muzio², Laura Guida¹, Fabio Salcuni¹, Michele Laurenziello¹, Gaetano Illuzzi¹, Michele Tepedino³

Affiliations

¹ Department of Clinical and Experimental Medicine, Dental School of Foggia, University of Foggia, Foggia, Italy.
² Department of Orthodontics, University of Ferrara, Ferrara, Italy.
³ Department of Biotecnologica and Applied Clinical Sciences, Dental School of L'Aquila, University of L'Aquila, L'Aquila, Italy.

PMID: 35171757
DOI: 10.1080/08869634.2022.2041271

Abstract

Objective: The mandibular advancement device (MAD) is currently suggested in patients with mild to moderate obstructive sleep apnea (OSA). This study investigated the effects of a new fully customizable MAD-type device called, "It Makes You Sleep" (IMYS), in patients with mild to moderate OSA.

Methods: Sixteen patients (14 men and 2 women; mean age 62; SD ± 11 years) were retrospectively enrolled. Each patient received home sleep apnea testing (HSAT) at baseline (T0) and after three months (T1) of IMYS treatment. The Apnea-Hypopnea Index (AHI), the Oxygen Desaturation Index (ODI), the Minimum Oxygen Saturation (minSO2) and the Medium Oxygen Saturation (medSO2) were analyzed.

Results: From T0 to T1, the IMYS treatment showed a significant reduction of AHI and ODI and a significant increase of minSO2 and medSO2.

Conclusion: The IMYS appliance is an effective device for treating mild or moderate OSA.

Keywords: Obstructive sleep apnea; mandibular advancement; oral device.